Description

ST2 (Suppression of Tumorigenicity 2) is a receptor for interleukin-33 (IL-33), and its soluble form (sST2) is an important prognostic marker for heart failure and myocardial fibrosis.

Specifications

Product Details
Source	Human
Expression Host	Mammalian cell
Molecular Mass	36 kDa
Formulation	Purified, Liquid
Purification	>95%
Buffer	PBS, 5% Mannital, 0.01% Tween 80, pH7.4
Storage	For long term storage, the product should be stored at -20°C or lower.
Validity	3 years

Instructions for Use

Dissolve the lyophilized powder in an appropriate sterile buffer in a sterile environment before use.
Prepare and dilute the solution according to experimental requirements to ensure accurate and reproducible results.
Do not mix with other similar products to avoid cross-reactivity and potential interference.

Cautions

• Research Use Only: This product is not suitable for clinical diagnostics or therapeutic applications.

• Preservation: Handle according to instructions to preserve its activity and stability.

• Support: Contact our technical support team if you encounter any issues or questions.

Documents

📄 Download COA 📄 Download MSDS

Recombinant ST2